One business, one mission: improving brain health through the application of digital technologies.
Established in 2004 and listed as a public company in October 2013, IXICO has established itself as a trusted partner to the global biopharma industry, providing technology-enabled speciality services in clinical trials.
Our neuroscience expertise in image analysis and data management provides specialist data analytics services, which are applied on some of the most important clinical trials in neuroscience (e.g. Dementia, Huntington's disease, Parkinson's disease, multiple sclerosis). This way IXICO is providing valuable insights to disease progression and patient safety, enabling our clients to make better informed decisions earlier in the clinical development pathway.
And our people make all this happen. We have a passionate, dedicated team, bringing together the essential skills needed to innovate and develop cutting-edge tec...
(click "adview.online" below for full description)